A Retrospective Cohort Study to Assess the Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Rheumatoid Arthritis and Used in the Treatment of Atopic Dermatitis in Nordic Countries

This study evaluates the long-term safety of baricitinib among patients with rheumatoid arthritis and among patients with atopic dermatitis.